RI-MUHC leads study to identify a novel mechanism driving aggressive prostate cancer
This international research collaboration may lead to a shift in the clinical management of patients...
Improving the performance of rapid tests through clear instructions
Researchers at the RI-MUHC investigate whether rapid antigenic detection tests for COVID-19 could be adequately used in the workplace.
New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec
The project will use artificial intelligence (A.I.), wearable...
Stress in healthcare workers: a model to help us rethink challenges
Better understand for better support: a new model developed by RI-MUHC researchers illustrates the relationships between the various factors...
COVID-19 vaccination highly effective in individuals with immune-related inflammatory diseases
RI-MUHC researcher Sasha Bernatsky is senior author of a nationwide study
$6.7 million to study the impacts of COVID-19 on children
Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...
Immunotherapy showing significant advancements in lung cancer treatment
Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results
Benefits of fluvoxamine confirmed in new study
Preventing hospitalization following COVID-19 infection in vulnerable populations
The unexpected role of chloride channels in a rare neurological disorder
A new study finds mutations affecting the chloride channel of a glutamate transport protein in a rare disorder...
Where immune cells are located is critical for cancer immune therapy, a new study shows
An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...